Security key
53566P109
Lineage Cell Therapeutics, Inc. - Common Stock (LCTX)
CUSIP: 53566P109
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 7,830,065
- Total 13F value
- $10,257,236
- Share change
- -78,803
- SEC-reported price per share
- $1.31
- Number of holders
- 31
- Value change
- -$127,435
- Number of buys
- 8
- Number of sells
- 8
- Shares outstanding
- 248,782,811
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
31
Top holders
10
LCTX full security history
Ownership snapshot
Full 13F holder table
Lineage Cell Therapeutics, Inc. SEC filings
Lineage Cell Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 53566P109
Recent filing periods:
Ownership snapshot
Top reported holders of LCTX - Lineage Cell Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BROADWOOD PARTNERS, L.P.
Disclosed value leader
BROADWOOD PARTNERS, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 23%
13D/G row: BROADWOOD PARTNERS, L.P.
Showing 1-6 of 15 holder rows.
Quick read
BROADWOOD PARTNERS, L.P. leads the comparable SEC ownership view at 23%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BROADWOOD PARTNERS, L.P.'s linked filing trail.
Comparable ownership
Top 5
BROADWOOD PARTNERS, L.P.
23%
BlackRock, Inc.
5.3%
Jorey Chernett
5%
BROADWOOD CAPITAL INC
20%
VANGUARD CAPITAL MANAGEMENT LLC
3.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. |
13D/G
3/4/5
NEAL C. BRADSHER · Director, 10%+ Owner
|
23%
|
$97,763,723
57,848,357 shares
|
$0 | 12 Nov 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
5.3%
|
$17,272,991
13,185,489 shares
|
+$14,345,737 | 30 Jun 2026 |
| Jorey Chernett |
13D/G
Chernett Jorey
|
5%
|
$13,848,454
11,445,003 shares
|
$0 | 22 Sep 2025 |
| BROADWOOD CAPITAL INC |
13F
Company
|
20%
|
$78,306,367
49,560,992 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
3.3%
|
$13,143,522
8,318,685 shares
|
— | 31 Mar 2026 |
| Defender Capital, LLC. |
13F
Company
|
2.7%
|
$10,632,766
6,729,599 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
31
Shares
7,830,065
Rows available
31
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
128
Q2 2026 holders
31
Holder diff
-97
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend